Adagene announces up to $25 million strategic investment from Sanofi
(NasdaqGM:ADAG),(Paris:SAN.PA), – Sanofi to exercise option on third SAFEbody discovery program and sponsor combination clinical trial with muzastotug – Company expects proceeds to extend cash runway into 2027 SAN DIEGO and SUZHOU, China, July 01, 2025 (GLOBE NEWSWIRE) — Adagene Inc. (“Adagene or the Company”) (Nasdaq: ADAG), a company transforming the discovery and development of […]